In addition, certain tumour types, such as leukaemia, hepatocellular carcinoma, and colorectal cancer, exhibit frequent post‐translational modifications—particularly ubiquitination and palmitoylation—that impair MHC expression and facilitate immune escape, thereby presenting additional opportunities for therapeutic intervention.80, 150. The gene discussed is HLA-C; the disease is neoplasm.